464 related articles for article (PubMed ID: 9713360)
1. Undifferentiated carcinoma of the pancreas: analysis of intermediate filament profile and Ki-ras mutations provides evidence of a ductal origin.
Hoorens A; Prenzel K; Lemoine NR; Klöppel G
J Pathol; 1998 May; 185(1):53-60. PubMed ID: 9713360
[TBL] [Abstract][Full Text] [Related]
2. Tumors of the pancreas with osteoclast-like and pleomorphic giant cells: an immunohistochemical and ploidy study.
Deckard-Janatpour K; Kragel S; Teplitz RL; Min BH; Gumerlock PH; Frey CF; Ruebner BH
Arch Pathol Lab Med; 1998 Mar; 122(3):266-72. PubMed ID: 9823867
[TBL] [Abstract][Full Text] [Related]
3. Origin of giant cells in osteoclast-like giant cell tumors of the pancreas.
Sakai Y; Kupelioglu AA; Yanagisawa A; Yamaguchi K; Hidaka E; Matsuya S; Ohbuchi T; Tada Y; Saisho H; Kato Y
Hum Pathol; 2000 Oct; 31(10):1223-9. PubMed ID: 11070115
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation.
Hoorens A; Lemoine NR; McLellan E; Morohoshi T; Kamisawa T; Heitz PU; Stamm B; Rüschoff J; Wiedenmann B; Klöppel G
Am J Pathol; 1993 Sep; 143(3):685-98. PubMed ID: 8362971
[TBL] [Abstract][Full Text] [Related]
5. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas.
Weyrer K; Feichtinger H; Haun M; Weiss G; Ofner D; Weger AR; Umlauft F; Grünewald K
Lab Invest; 1996 Jan; 74(1):279-89. PubMed ID: 8569192
[TBL] [Abstract][Full Text] [Related]
6. Osteoclast-like giant cell tumor in mucinous cystadenocarcinoma of the pancreas: an immunohistochemical and molecular analysis.
Sedivy R; Kalipciyan M; Mazal PR; Wolf B; Wrba F; Karner-Hanusch J; Mühlbacher F; Mader RM
Cancer Detect Prev; 2005; 29(1):8-14. PubMed ID: 15734212
[TBL] [Abstract][Full Text] [Related]
7. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G
Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563
[TBL] [Abstract][Full Text] [Related]
8. K-ras oncogene mutations in osteoclast-like giant cell tumors of the pancreas and liver: genetic evidence to support origin from the duct epithelium.
Westra WH; Sturm P; Drillenburg P; Choti MA; Klimstra DS; Albores-Saavedra J; Montag A; Offerhaus GJ; Hruban RH
Am J Surg Pathol; 1998 Oct; 22(10):1247-54. PubMed ID: 9777987
[TBL] [Abstract][Full Text] [Related]
9. Anaplastic carcinoma of the pancreas associated with a mucinous cystic adenocarcinoma. A case report and review of the literature.
Pan ZG; Wang B
JOP; 2007 Nov; 8(6):775-82. PubMed ID: 17993730
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
[TBL] [Abstract][Full Text] [Related]
11. Undifferentiated carcinoma with osteoclast-like giant cells of the pancreas and periampullary region.
Molberg KH; Heffess C; Delgado R; Albores-Saavedra J
Cancer; 1998 Apr; 82(7):1279-87. PubMed ID: 9529019
[TBL] [Abstract][Full Text] [Related]
12. Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas.
Ueda S; Fukamachi K; Matsuoka Y; Takasuka N; Takeshita F; Naito A; Iigo M; Alexander DB; Moore MA; Saito I; Ochiya T; Tsuda H
Carcinogenesis; 2006 Dec; 27(12):2497-510. PubMed ID: 16774944
[TBL] [Abstract][Full Text] [Related]
13. Undifferentiated (anaplastic) carcinoma of the pancreas with osteoclast-like giant cells showing various degree of pancreas duct involvement. A case report and literature review.
Maksymov V; Khalifa MA; Bussey A; Carter B; Hogan M
JOP; 2011 Mar; 12(2):170-6. PubMed ID: 21386647
[TBL] [Abstract][Full Text] [Related]
14. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
Adsay NV; Basturk O; Cheng JD; Andea AA
Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
[TBL] [Abstract][Full Text] [Related]
15. Giant-cell containing neoplasms of the pancreas: an aspiration cytology study.
Layfield LJ; Bentz J
Diagn Cytopathol; 2008 Apr; 36(4):238-44. PubMed ID: 18335561
[TBL] [Abstract][Full Text] [Related]
16. Ki-ras and p53 gene mutations in pancreatic ductal carcinoma: a relationship with tumor phenotype and survival.
Sessa F; Bonato M; Bisoni D; Ranzani GN; Capella C
Eur J Histochem; 1998; 42 Spec No():67-76. PubMed ID: 10076772
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
Uemura K; Hiyama E; Murakami Y; Kanehiro T; Ohge H; Sueda T; Yokoyama T
Oncol Rep; 2003; 10(2):277-83. PubMed ID: 12579258
[TBL] [Abstract][Full Text] [Related]
18. Detection of epithelial- and neural type of intermediate filament proteins in human lung tumors.
Ramaekers F; Broers J; Rot MK; Oostendorp T; Wagenaar S; Vooijs P
Acta Histochem Suppl; 1987; 34():45-56. PubMed ID: 3033739
[TBL] [Abstract][Full Text] [Related]
19. Mutations of the Ki-ras oncogene in carcinoma of the endometrium.
Caduff RF; Johnston CM; Frank TS
Am J Pathol; 1995 Jan; 146(1):182-8. PubMed ID: 7856726
[TBL] [Abstract][Full Text] [Related]
20. Early undifferentiated pancreatic carcinoma with osteoclastlike giant cells: direct evidence for ductal evolution.
Bergmann F; Esposito I; Michalski CW; Herpel E; Friess H; Schirmacher P
Am J Surg Pathol; 2007 Dec; 31(12):1919-25. PubMed ID: 18043049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
